| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.37B | 20.64B | 16.14B | 15.38B | 13.86B | 11.77B |
| Gross Profit | 5.95B | 5.11B | 2.92B | 2.40B | 2.76B | 2.27B |
| EBITDA | 1.84B | 1.51B | 970.38M | 442.61M | 283.37M | -111.84M |
| Net Income | 480.39M | 287.56M | 280.17M | 348.26M | 573.60M | -210.81M |
Balance Sheet | ||||||
| Total Assets | 15.24B | 15.96B | 8.22B | 7.85B | 7.26B | 7.16B |
| Cash, Cash Equivalents and Short-Term Investments | 5.59B | 6.49B | 3.12B | 2.67B | 2.00B | 2.83B |
| Total Debt | 50.59M | 67.48M | 1.06M | 8.64M | 23.25M | 33.70M |
| Total Liabilities | 7.11B | 7.88B | 4.28B | 4.16B | 3.90B | 3.07B |
| Stockholders Equity | 8.05B | 8.02B | 3.93B | 3.69B | 3.36B | 4.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 738.97M | 1.01B | 779.02M | 614.77M | 313.47M |
| Operating Cash Flow | 0.00 | 1.31B | 1.16B | 891.61M | 845.81M | 347.46M |
| Investing Cash Flow | 0.00 | -640.15M | -609.55M | -124.14M | -308.98M | 39.42M |
| Financing Cash Flow | 0.00 | -352.44M | -90.43M | -97.72M | -1.36B | -126.83M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥13.23B | 13.00 | ― | 1.84% | 22.56% | 1669.86% | |
70 Outperform | ¥16.92B | 16.20 | ― | 3.04% | -3.50% | -7.58% | |
69 Neutral | ¥115.53B | 10.12 | ― | 1.71% | 7.01% | 72.94% | |
68 Neutral | ¥876.99B | 24.11 | 7.76% | 1.67% | 0.97% | 12.23% | |
64 Neutral | ¥371.59B | 6.57 | 7.48% | 1.79% | 6.63% | 80.44% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
57 Neutral | ¥35.70B | 5.84 | ― | 2.17% | 1.78% | 1067.85% |